SCHEMBL13533880

SCHEMBL13533880

C#CCC(=O)NC(CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 1/20 0.39
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ TDP1 Q9NUW8 3/20 0.33
▸ MAPT P10636 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CTSK P43235 3/20 0.32
▸ CTSS P25774 2/20 0.32
▸ CACNA1B Q00975 5/20 0.32
▸ KLK5 Q9Y337 2/20 0.32
▸ POLB P06746 2/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12712213 0.87 CYP2D6 (0.37) CYP2D6CYP1A2CYP2C9CYP2C19HTT
SCHEMBL30826518 0.83 CYP2D6 (0.42) CYP2D6CYP1A2CYP2C9CYP2C19HTT
SCHEMBL22398798 0.81 CYP2D6 (0.41) CYP2D6CYP1A2CYP2C9CYP2C19HTT
SCHEMBL22398796 0.81 CYP2D6 (0.41) CYP2D6CYP1A2CYP2C9CYP2C19HTT
SCHEMBL4744955 0.81 CYP2D6 (0.41) CYP2D6CYP1A2CYP2C9CYP2C19HTT
SCHEMBL22398775 0.81 CYP2D6 (0.41) CYP2D6CYP1A2CYP2C9CYP2C19HTT
SCHEMBL12712229 0.80 KLK5 (0.36) CYP2D6HDAC3HDAC1HDAC2HDAC8
SCHEMBL22398295 0.80 CYP2D6 (0.40) CYP2D6CYP1A2CYP2C9CYP2C19HTT
SCHEMBL3497195 0.79 CYP2D6 (0.38) CYP2D6CYP1A2CYP2C9CYP2C19HTT
SCHEMBL31023961 0.79 CYP2D6 (0.44) CYP2D6CYP1A2CYP2C9CYP2C19HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8932992-B2 Templated molecules and methods for using such molecules NUEVOLUTION A/S (DK) 2015-01-13 — — US disclosed
US-8932992-B2 Templated molecules and methods for using such molecules NUEVOLUTION A/S (DK) 2015-01-13 — — US disclosed
US-20100016177-A1 TEMPLATED MOLECULES AND METHODS FOR USING SUCH MOLECULES NUEVOLUTION A/S (DK) 2010-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016177-A1 TEMPLATED MOLECULES AND METHODS FOR USING SUCH MOLECULES INTS6, ABL1, INMT CYP2D6 568/4885CYP1A2 1759/4885CYP2C9 2418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback